Voriconazole Tablets — Class II drug recall D-0307-2025
Terminated recall by Amerisource Health Services LLC, reported 2025-04-09, distributed nationwide. cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact th
| Recall number | D-0307-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Amerisource Health Services LLC, Columbus, OH, United States |
| Recall initiated | 2025-03-24 |
| Classified | 2025-03-28 |
| Reported by FDA | 2025-04-09 |
| Terminated | 2026-02-10 |
| Distributed | Nationwide (US) |
| Quantity | 889 cartons |
| Reason classes | cgmp |
| NDC | 60687-0273, 60687-0273-11, 60687-0273-21, 60687-0294, 60687-0294-11, 60687-0294-21 |
| Lot numbers | 1014138 |
| Expiration dates | 2025-04-30 |
Product
Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 60687-294-21, Unit Dose NDC 60687-294-11.
Reason for recall
cGMP Deviations: Received notification from their supplier requesting they perform a recall due to the fact they repackaged the product.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0307-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.